Circle Pharma is a pre-clinical stage, life sciences company discovering and developing macrocycle therapeutics, with an initial focus in oncology. Our discovery platform allows us to address challenging therapeutic targets such as intracellular protein-protein interactions.
Our structure-based drug discovery platform encompasses target affinity, cell permeability, medicinal chemistry and macrocycle synthesis, tightly integrated with biochemistry and cellular biology. We are closing a substantial Series B round of funding and are expanding our team. We seek candidates who desire to make key contributions to help drive our growth.
For more information about Circle Pharma, please look through our website.